Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Hepatitis B | Research article

Hepatitis B vaccination coverage across India: exploring the spatial heterogeneity and contextual determinants

Authors: Junaid Khan, Apurba Shil, Sanjay K. Mohanty

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Although hepatitis B vaccinations have been integrated in the Universal Immunization Program (UIP) in India over a decade, only half of the children are immunized against hepatitis B. The national average in hepatitis B vaccination conceals large variations across states, districts and socio-economic groups. In this context, the aim of this paper is to examine the spatial heterogeneity and contextual determinants of hepatitis B vaccination across the districts of India.

Methods

Using data of 199,899 children aged 12–59 months from the National Family Health Survey-4 (NFHS-4), 2015–16 we have examined the district level spatial distribution and clustering of hepatitis B vaccination with the help of Moran’s I and Local Indicator of Spatial Autocorrelation (LISA) measures. We investigated the low coverage of HBV vaccination using spatial autoregressive models (SAR) at the meso scale. And we applied multivariate binary logistic regression analysis to understand the micro-level predictors of hepatitis B vaccination.

Results

In 2015–16, 45% of the children aged 12–59 months were not vaccinated against hepatitis B in India. The coverage of hepatitis B vaccine across the districts of India showed a highly significant spatial dependence (Moran’s I = 0.580). Bivariate Moran’s I confirmed the spatial clustering of hepatitis B vaccination with mother’s education, full antenatal care (ANC) utilization, post natal care (PNC) utilization, institutional births and registration of births at the district level. Districts with a very low coverage of HBV vaccine are clustered in the western, north-eastern regions and in some parts of central India. At the unit (child) level, children’s hepatitis B immunization status is mostly determined by the socio-economic and demographic characteristics like their mother’s educational status, caste, religion, household’s wealth condition, birth order, year of birth and the region they belong to.

Conclusions

District level variation in hepatitis B vaccination is spatially heterogeneous and clustered in India with a strong neighbourhood effect. Uptake of hepatitis B vaccine among Indian children is predominantly dependent upon their socio-economic and demographic characteristics.
Appendix
Available only for authorised users
Footnotes
1
The prevalence of hepatitis B surface antigen (HBsAg) tells about the positive surface antigen of the hepatitis B virus indicating the chronic carriers of hepatitis B virus.
 
2
According to the definition of NFHS-4, improved sources of drinking water include piped water, public taps, standpipes, tube wells, boreholes, protected dug wells and springs, rainwater and community reverse osmosis (RO) plants.
 
3
Breastfed children who received four or more food groups with a minimum meal frequency of 2-3 times a day, i.e., the children received solid or semi solid foods at least two- three times from the following food groups - a. infant formula, milk other than breast milk, cheese or yogurt or other milk products; b. foods made from grains or roots, including porridge or gruel, fortified baby food; c. vitamin A-rich fruits and vegetables; d. other fruits and vegetables; e. eggs; f. meat, poultry, fish, shellfish, or organ meats; g. beans, peas, lentils, or nuts; h. foods made with oil, fat, ghee, or butter
 
Literature
1.
go back to reference Organization WH. Global policy report on the prevention and control of viral hepatitis in WHO member states: World Health Organization; 2013. Organization WH. Global policy report on the prevention and control of viral hepatitis in WHO member states: World Health Organization; 2013.
2.
go back to reference Organization WH. Prevention of hepatitis B in India: an overview. In: Prevention of Hepatitis B in India: an overview; 2002. Organization WH. Prevention of hepatitis B in India: an overview. In: Prevention of Hepatitis B in India: an overview; 2002.
3.
go back to reference Demirjian A, Levy O. Safety and efficacy of neonatal vaccination. Eur J Immunol. 2009;39(1):36–46.CrossRef Demirjian A, Levy O. Safety and efficacy of neonatal vaccination. Eur J Immunol. 2009;39(1):36–46.CrossRef
4.
go back to reference Wiktor SZ, Hutin YJ. The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts. Lancet. 2016;388(10049):1030–1.CrossRef Wiktor SZ, Hutin YJ. The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts. Lancet. 2016;388(10049):1030–1.CrossRef
5.
go back to reference Kumar HH, Nambiar RP, Mohapatra S, Khanna A, Praveen R, Bhawana DS. A cross-sectional study on hepatitis B vaccination status and post-exposure prophylaxis practices among health Care Workers in Teaching Hospitals of Mangalore. Ann Glob Health. 2015;81(5):664–8.CrossRef Kumar HH, Nambiar RP, Mohapatra S, Khanna A, Praveen R, Bhawana DS. A cross-sectional study on hepatitis B vaccination status and post-exposure prophylaxis practices among health Care Workers in Teaching Hospitals of Mangalore. Ann Glob Health. 2015;81(5):664–8.CrossRef
6.
go back to reference Organization WH. Hepatitis B vaccines. Wkly Epidemiol Rec. 2009;84(40):405–19. Organization WH. Hepatitis B vaccines. Wkly Epidemiol Rec. 2009;84(40):405–19.
7.
go back to reference Organization WH. World Health Organization Hepatitis B Fact Sheet. Geneva: World Health Organization. Organization WH. World Health Organization Hepatitis B Fact Sheet. Geneva: World Health Organization.
8.
go back to reference Organization WH: Media Centre. Hepatitis B. Accessed 4 Sept 2013; 2013. Organization WH: Media Centre. Hepatitis B. Accessed 4 Sept 2013; 2013.
9.
go back to reference Komatsu H. Hepatitis B virus: where do we stand and what is the next step for eradication? World J Gastroenterol. 2014;20(27):8998.PubMedPubMedCentral Komatsu H. Hepatitis B virus: where do we stand and what is the next step for eradication? World J Gastroenterol. 2014;20(27):8998.PubMedPubMedCentral
10.
go back to reference Lahariya C, Subramanya B, Sosler S. An assessment of hepatitis B vaccine introduction in India: lessons for roll out and scale up of new vaccines in immunization programs. Indian J Public Health. 2013;57(1):8.CrossRef Lahariya C, Subramanya B, Sosler S. An assessment of hepatitis B vaccine introduction in India: lessons for roll out and scale up of new vaccines in immunization programs. Indian J Public Health. 2013;57(1):8.CrossRef
11.
go back to reference Organization WH: Global hepatitis report 2017. 2017. Organization WH: Global hepatitis report 2017. 2017.
12.
go back to reference Organization WH. Operational guidelines for hepatitis B vaccine introduction in the universal immunization Programme, vol. 94. New Delhi: Ministry of Health & Family Welfare, Government of India; 2011. Organization WH. Operational guidelines for hepatitis B vaccine introduction in the universal immunization Programme, vol. 94. New Delhi: Ministry of Health & Family Welfare, Government of India; 2011.
14.
go back to reference Datar A, Mukherji A, Sood N. Health infrastructure & immunization coverage in rural India. Indian J Med Res. 2007;125(1):31.PubMed Datar A, Mukherji A, Sood N. Health infrastructure & immunization coverage in rural India. Indian J Med Res. 2007;125(1):31.PubMed
15.
go back to reference Verma R, Khanna P, Prinja S, Rajput M, Chawla S, Bairwa M. Hepatitis B vaccine in national immunization schedule: a preventive step in India. Hum Vaccin. 2011;7(12):1387–8.CrossRef Verma R, Khanna P, Prinja S, Rajput M, Chawla S, Bairwa M. Hepatitis B vaccine in national immunization schedule: a preventive step in India. Hum Vaccin. 2011;7(12):1387–8.CrossRef
16.
go back to reference Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM. Systematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr. 2007;44(9):663.PubMed Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM. Systematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr. 2007;44(9):663.PubMed
17.
go back to reference Nayak N, Panda S, Bhan M, Guha D, Zuckerman A. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol. 1987;21(2):137–45.CrossRef Nayak N, Panda S, Bhan M, Guha D, Zuckerman A. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol. 1987;21(2):137–45.CrossRef
18.
19.
go back to reference International Institute for Population Sciences (IIPS) and ICF. National Family Health Survey (NFHS-4), 2015-16: Mumbai: IIPS; 2017. International Institute for Population Sciences (IIPS) and ICF. National Family Health Survey (NFHS-4), 2015-16: Mumbai: IIPS; 2017.
20.
go back to reference Croft TN, Marshall AMJ, Allen CK, et al. Guide to DHS Statistics. Rockville: ICF; 2018. Croft TN, Marshall AMJ, Allen CK, et al. Guide to DHS Statistics. Rockville: ICF; 2018.
21.
go back to reference Binyaruka P, Borghi J. Validity of parental recalls to estimate vaccination coverage: evidence from Tanzania. BMC Health Serv Res. 2018;18(1):440.CrossRef Binyaruka P, Borghi J. Validity of parental recalls to estimate vaccination coverage: evidence from Tanzania. BMC Health Serv Res. 2018;18(1):440.CrossRef
22.
go back to reference Mohanty SK, Fink G, Chauhan RK, Canning D. Distal determinants of fertility decline: evidence from 640 Indian districts. Demogr Res. 2016;34:373–406.CrossRef Mohanty SK, Fink G, Chauhan RK, Canning D. Distal determinants of fertility decline: evidence from 640 Indian districts. Demogr Res. 2016;34:373–406.CrossRef
23.
go back to reference Khan J, Shil A, Prakash R. Exploring the spatial heterogeneity in different doses of vaccination coverage in India. PLoS One. 2018;13(11):e0207209.CrossRef Khan J, Shil A, Prakash R. Exploring the spatial heterogeneity in different doses of vaccination coverage in India. PLoS One. 2018;13(11):e0207209.CrossRef
24.
go back to reference Ntozini R, Marks SJ, Mbuya MN, Gerema G, Mutasa B, Julian TR, Schwab KJ, Humphrey JH, Zungu LI, Team SHINET. Using geographic information systems and spatial analysis methods to assess household water access and sanitation coverage in the SHINE trial. Clin Infect Dis. 2015;61(suppl_7):S716–25.CrossRef Ntozini R, Marks SJ, Mbuya MN, Gerema G, Mutasa B, Julian TR, Schwab KJ, Humphrey JH, Zungu LI, Team SHINET. Using geographic information systems and spatial analysis methods to assess household water access and sanitation coverage in the SHINE trial. Clin Infect Dis. 2015;61(suppl_7):S716–25.CrossRef
25.
go back to reference Herliana P, Douiri A. Determinants of immunisation coverage of children aged 12–59 months in Indonesia: a cross-sectional study. BMJ Open. 2017;7(12):e015790.CrossRef Herliana P, Douiri A. Determinants of immunisation coverage of children aged 12–59 months in Indonesia: a cross-sectional study. BMJ Open. 2017;7(12):e015790.CrossRef
26.
go back to reference IIPS I. National Family Health Survey (NFHS-4), 2015–16. Mumbai: International Institute for Population Sciences; 2017. IIPS I. National Family Health Survey (NFHS-4), 2015–16. Mumbai: International Institute for Population Sciences; 2017.
27.
go back to reference Etana B, Deressa W. Factors associated with complete immunization coverage in children aged 12–23 months in ambo Woreda, Central Ethiopia. BMC Public Health. 2012;12(1):566.CrossRef Etana B, Deressa W. Factors associated with complete immunization coverage in children aged 12–23 months in ambo Woreda, Central Ethiopia. BMC Public Health. 2012;12(1):566.CrossRef
28.
go back to reference Kahn GD, Thacker D, Nimbalkar S, Santosham M. High cost is the primary barrier reported by physicians who prescribe vaccines not included in India’s universal immunization program. J Trop Pediatr. 2014;60(4):287–91.CrossRef Kahn GD, Thacker D, Nimbalkar S, Santosham M. High cost is the primary barrier reported by physicians who prescribe vaccines not included in India’s universal immunization program. J Trop Pediatr. 2014;60(4):287–91.CrossRef
29.
go back to reference Mathew JL. Inequity in childhood immunization in India: a systematic review. Indian Pediatr. 2012;49(3):203–23.CrossRef Mathew JL. Inequity in childhood immunization in India: a systematic review. Indian Pediatr. 2012;49(3):203–23.CrossRef
30.
go back to reference Sarma S. Demand for outpatient healthcare. Appl Health Econ Health Policy. 2009;7(4):265–77.CrossRef Sarma S. Demand for outpatient healthcare. Appl Health Econ Health Policy. 2009;7(4):265–77.CrossRef
31.
go back to reference Prakash C. Crucial factors that influence cost-effectiveness of universal hepatitis B immunization in India. Int J Technol Assess Health Care. 2003;19(1):28–40.CrossRef Prakash C. Crucial factors that influence cost-effectiveness of universal hepatitis B immunization in India. Int J Technol Assess Health Care. 2003;19(1):28–40.CrossRef
32.
go back to reference Miller MA, Kane M. Routine hepatitis B immunisation in India: cost-effectiveness assessment. Indian J Pediatr. 2000;67(4):299–300.CrossRef Miller MA, Kane M. Routine hepatitis B immunisation in India: cost-effectiveness assessment. Indian J Pediatr. 2000;67(4):299–300.CrossRef
33.
go back to reference Creati M, Saleh A, Ruff TA, Stewart T, Otto B, Sutanto A, Clements CJ. Implementing the birth dose of hepatitis B vaccine in rural Indonesia. Vaccine. 2007;25(32):5985–93.CrossRef Creati M, Saleh A, Ruff TA, Stewart T, Otto B, Sutanto A, Clements CJ. Implementing the birth dose of hepatitis B vaccine in rural Indonesia. Vaccine. 2007;25(32):5985–93.CrossRef
34.
go back to reference Sobel HL, Mantaring JB, Cuevas F, Ducusin JV, Thorley M, Hennessey KA, Nyunt-U S. Implementing a national policy for hepatitis B birth dose vaccination in Philippines: lessons for improved delivery. Vaccine. 2011;29(5):941–5.CrossRef Sobel HL, Mantaring JB, Cuevas F, Ducusin JV, Thorley M, Hennessey KA, Nyunt-U S. Implementing a national policy for hepatitis B birth dose vaccination in Philippines: lessons for improved delivery. Vaccine. 2011;29(5):941–5.CrossRef
35.
go back to reference Murakami H, Van Cuong N, Huynh L, Hipgrave DB. Implementation of and costs associated with providing a birth-dose of hepatitis B vaccine in Viet Nam. Vaccine. 2008;26(11):1411–9.CrossRef Murakami H, Van Cuong N, Huynh L, Hipgrave DB. Implementation of and costs associated with providing a birth-dose of hepatitis B vaccine in Viet Nam. Vaccine. 2008;26(11):1411–9.CrossRef
36.
go back to reference Lakew Y, Bekele A, Biadgilign S. Factors influencing full immunization coverage among 12–23 months of age children in Ethiopia: evidence from the national demographic and health survey in 2011. BMC Public Health. 2015;15(1):728.CrossRef Lakew Y, Bekele A, Biadgilign S. Factors influencing full immunization coverage among 12–23 months of age children in Ethiopia: evidence from the national demographic and health survey in 2011. BMC Public Health. 2015;15(1):728.CrossRef
37.
go back to reference Murhekar MV, Murhekar KM, Sehgal SC. Epidemiology of hepatitis B virus infection among the tribes of Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg. 2008;102(8):729–34.CrossRef Murhekar MV, Murhekar KM, Sehgal SC. Epidemiology of hepatitis B virus infection among the tribes of Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg. 2008;102(8):729–34.CrossRef
Metadata
Title
Hepatitis B vaccination coverage across India: exploring the spatial heterogeneity and contextual determinants
Authors
Junaid Khan
Apurba Shil
Sanjay K. Mohanty
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7534-2

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue